Angel M-L Chim

Suggest Changes
Learn More
BACKGROUND The timing of antiviral therapy cessation in hepatitis B e antigen (HBeAg)-negative patients is controversial. Here, we aimed to investigate the role of HBV DNA and hepatitis B surface(More)
BACKGROUND Metabolic syndrome is a known risk factor of cirrhosis in chronic hepatitis B (CHB). AIM To investigate the effects of coincidental metabolic syndrome on liver fibrosis progression in(More)